A new trading day began on Tuesday, with Spruce Biosciences Inc (NASDAQ: SPRB) stock price down -58.02% from the previous day of trading, before settling in for the closing price of $0.31. SPRB’s price has ranged from $0.26 to $0.87 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 46.90%. With a float of $28.56 million, this company’s outstanding shares have now reached $41.30 million.
In terms of profitability, gross margin is -14.36%, operating margin of -608.94%, and the pretax margin is -555.23%.
Spruce Biosciences Inc (SPRB) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Spruce Biosciences Inc is 30.86%, while institutional ownership is 23.54%.
Spruce Biosciences Inc (SPRB) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 46.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 29.61% during the next five years compared to -22.95% drop over the previous five years of trading.
Spruce Biosciences Inc (NASDAQ: SPRB) Trading Performance Indicators
Here are Spruce Biosciences Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.36. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.96, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -0.67 in one year’s time.
Technical Analysis of Spruce Biosciences Inc (SPRB)
Looking closely at Spruce Biosciences Inc (NASDAQ: SPRB), its last 5-days average volume was 6.3 million, which is a jump from its year-to-date volume of 0.8 million. As of the previous 9 days, the stock’s Stochastic %D was 54.47%. Additionally, its Average True Range was 0.04.
During the past 100 days, Spruce Biosciences Inc’s (SPRB) raw stochastic average was set at 1.45%, which indicates a significant decrease from 3.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 360.10% in the past 14 days, which was higher than the 151.10% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3463, while its 200-day Moving Average is $0.4418. However, in the short run, Spruce Biosciences Inc’s stock first resistance to watch stands at $0.1724. Second resistance stands at $0.2129. The third major resistance level sits at $0.2363. If the price goes on to break the first support level at $0.1085, it is likely to go to the next support level at $0.0851. Now, if the price goes above the second support level, the third support stands at $0.0446.
Spruce Biosciences Inc (NASDAQ: SPRB) Key Stats
With a market capitalization of 5.45 million, the company has a total of 41,303K Shares Outstanding. Currently, annual sales are 10,090 K while annual income is -47,920 K. The company’s previous quarter sales were 600 K while its latest quarter income was -8,670 K.
